Eiger BioPharmaceuticals, Inc.
11
Stacey G Jernigan
04/01/2024
04/18/2025
Yes
v
| SEALEDEXH, SealedDocument, REFORM, COMPLEX, jntadmn, LEAD, ClaimsAgent, EXHIBITS |
Assigned to: Chief Bankruptcy Jud Stacey G Jernigan Chapter 11 Voluntary Asset |
|
Debtor Eiger BioPharmaceuticals, Inc.
c/o Douglas Staut, CRO 2100 Ross Avenue Dallas, TX 75201 SANTA CLARA-CA Tax ID / EIN: 33-0971591 |
represented by |
Thomas Robert Califano
Sidley Austin LLP 787 Seventh Avenue New York, NY 10019 212-839-5575 Fax : 212-839-5599 Email: tom.califano@sidley.com Veronica A. Courtney
Sidley Austin LLP 1000 Louisiana Street Ste 5900 Houston, TX 77002 713-495-4572 Fax : 713-495-7799 Email: vcourtney@sidley.com William E Curtin
Sidley Austin LLP 787 Seventh Avenue New York, NY 10019 212-839-6745 Fax : 212-839-5599 Email: wcurtin@sidley.com Nathan Elner
Sidley Austin LLP 2021 McKinney Avenue Suite 2000 Dallas, TX 75201 212-839-5300 Email: nelner@sidley.com John Joseph Kuster
Sidley Austin LLP 787 Seventh Avenue New York, NY 10019 212-839-7336 Email: jkuster@sidley.com Jon Muenz
Sidley Austin LLP 787 7th Avenue New York, NY 10019 212-839-5901 Fax : 212-839-5599 Email: jmuenz@sidley.com Patrick J. Neligan, Jr.
Neligan LLP 4851 LBJ Freeway Suite 700 Dallas, TX 75244 214-912-9861 Email: pneligan@neliganlaw.com Charles Martin Persons, Jr.
Sidley Austin LLP 2020 McKinney Avenue, Suite 2000 Dallas, TX 75210 (214) 981-3300 Fax : (214) 981-3400 Email: charlespersons@paulhastings.com TERMINATED: 09/24/2024 Andrew J. Townsell
Sidley Austin LLP 787 7th Avenue New York, NY 10019 212-839-6793 Email: andrew.townsell@sidley.com Anne G. Wallice
Sidley Austin LLP 787 Seventh Avenue New York, NY 10019 212-839-6021 Email: anne.wallice@sidley.com |
U.S. Trustee United States Trustee
1100 Commerce Street Room 976 Dallas, TX 75202 214-767-8967 |
represented by |
Elizabeth Ziegler Young
U.S. Trustee Office 1100 Commerce Street, Room 976 Dallas, TX 75242 (214) 767-8967 Fax : (214) 767-8971 Email: elizabeth.a.young@usdoj.gov |
Creditor Committee Official Unsecured Creditors Committee
Munsch Hardt Kopf & Harr, P.C. 500 N. Akard Street Suite 4000 Dallas, TX 75201 214-855-7500 |
represented by |
Shira A. Baratz
Meland Budwick, P.A. 200 S. Biscayne Blvd., Suite 3200 MIami, FL 33131 305-358-6363 Fax : 305-358-1221 Email: sbarttz@melandbudwick.com Thomas Daniel Berghman
Munsch Hardt Kopf & Harr PC 500 N Akard Street, Suite 3800 Dallas, TX 75201-6659 (214) 855-7554 Fax : (214) 978-4346 Email: tberghman@munsch.com Michael S. Budwick
Meland Budwick, P.A. 200 S. Biscayne Blvd., Suite 3200 MIami, FL 33131 305-358-6363 Fax : 305-358-1221 Email: mbudwick@melandbudwick.com Daniel N. Gonzalez
Meland Budwick, PA 200 S. Biscayne Boulevard, Suite 3200 Miami, FL 33131 (305) 358-6363 Fax : (305) 358-1221 Email: dgonzalez@melandbudwick.com Meaghan E. Murphy
Meland Budwick, P.A. 200 S. Biscayne Blvd., Suite 3200 MIami, FL 33131 305-358-6363 Fax : 305-358-1221 Email: mmurphy@melandbudwick.com Garrick Chase Smith
Munsch Hardt Kopf & Harr, P.C. 500 N. Akard Street Suite 4000 Dallas, TX 75201 214-740-5110 Fax : 214-855-7584 Email: gsmith@munsch.com |
| Date Filed | # | Docket Text |
|---|---|---|
| 04/18/2025 | 828 | Order (I) Setting discovery and briefing schedule and (II) Related items (RE: related document(s)[729] Application for administrative expenses filed by Interested Party Sentynl Therapeutics, Inc., [777] Objection filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee, [779] Motion for Contempt filed by Interested Party Sentynl Therapeutics, Inc., [781] Motion to enforce filed by Interested Party Sentynl Therapeutics, Inc., [784] Sealed document per court order filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee, [787] Motion to enforce filed by Interested Party EIT Pharma, Inc., formerly known as Eiger InnoTherapeutics, Inc.). Hearing to be held on 4/29/2025 at 09:30 AM Dallas Judge Jernigan Ctrm for [729] and for [787] and for [781] and for [779] and for [784] and for [777], Entered on 4/18/2025 (Rielly, Bill) |
| 04/16/2025 | 822 | Request for transcript regarding a hearing held on 4/15/2025. The requested turn-around time is daily filed by Interested Party Sentynl Therapeutics, Inc.. (Ray, Hugh) |
| 04/16/2025 | 821 | Request for transcript regarding a hearing held on 4/15/2025. The requested turn-around time is daily filed by Interested Party EIT Pharma, Inc., formerly known as Eiger InnoTherapeutics, Inc.. (Brookner, Jason) |
| 04/15/2025 | 827 | Hearing held on 4/15/2025. (RE: related document(s) [787] Emergency Motion to enforce EIT Pharma, Inc., formerly known as Eiger InnoTherapeutics, Inc.'s Emergency Motion to Confirm Terms of Lonafarnib/Lambda Sale Order (related document(s): [558] Order on motion to sell) Filed by Interested Party EIT Pharma, Inc., formerly known as Eiger InnoTherapeutics, Inc.) (Appearances: H. Ray, III, J. Morris, J. Dickenson, R. Trechtor, and M. Stromberg for Senynl; W. Martin, R. Parisi, and M. Venus for Liquidating Trustee; J. Brookner and E. Shanks for EIT; C. Carson for Progeria Foundation. Nonevidentiary hearing (turned into status conference). After hearing statements of counsel, court determined this contested matter will be tried jointly with Sentynl Motions to Enforce Zokinvy Sale Order and Request for Allowance of an Administrative Expense claim, DE ## 729 & 779). Joint Scheduling Order to be submitted.) (Edmond, Michael) |
| 04/15/2025 | 826 | Status Conference Hearing held on 4/15/2025. (RE: related document(s) 781] Motion to enforce Sentynl Therapeutics, Inc.'s Motion (I) to Enforce the Zokinvy Sale Order and (II) For Contempt Against Eiger Innotherapeutics, Inc., (related document(s): [162] Order (generic)) Filed by Interested Party Sentynl Therapeutics, Inc. (Appearances: H. Ray, III, J. Morris, J. Dickenson, R. Trechtor, and M. Stromberg for Senynl; W. Martin, R. Parisi, and M. Venus for Liquidating Trustee; J. Brookner and E. Shanks for EIT; C. Carson for Progeria Foundation. Nonevidentiary status conference. After hearing statements of counsel, court determined this contested matter will be tried jointly with Request for Allowance of an Administrative Expense claim, DE # 729, all parties agreeing that no adversary proceeding is needed/requested. This matter will also be tried with EIT Motion at DE # 787. Joint Scheduling Order to be submitted.) (Edmond, Michael) |
| 04/15/2025 | 825 | Status Conference Hearing held on 4/15/2025. (RE: related document(s) [779] Motion for contempt against Eiger InnoTherapeutics, Inc. (n/k/a EIT Pharma, Inc.) regarding the Zokinvy Sale Order Sentynl Therapeutics, Inc.'s Motion (I) to Enforce the Zokinvy Sale Order and (II) For Contempt Against Eiger Innotherapeutics, Inc., filed by Interested Party Sentynl Therapeutics, Inc. (Appearances: H. Ray, III, J. Morris, J. Dickenson, R. Trechtor, and M. Stromberg for Senynl; W. Martin, R. Parisi, and M. Venus for Liquidating Trustee; J. Brookner and E. Shanks for EIT; C. Carson for Progeria Foundation. Nonevidentiary status conference. After hearing statements of counsel, court determined this contested matter will be tried jointly with Request for Allowance of an Administrative Expense claim, DE # 729, all parties agreeing that no adversary proceeding is needed/requested. This matter will also be tried with EIT Motion at DE # 787. Joint Scheduling Order to be submitted.) (Edmond, Michael) |
| 04/15/2025 | 824 | Hearing held on 4/15/2025. (RE: related document(s) [771] Objection to claim(s) of Creditor(s) Merck Sharp and Dohme LLC., filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee. (Agreed Order announced.) (Edmond, Michael) |
| 04/15/2025 | 823 | Status Conference Hearing held on 4/15/2025. (RE: related document(s) [729] Application for administrative expenses, Motion for Allowance of Administrative Expense Claim of Sentynl Therapeutics, Inc., filed by Interested Party Sentynl Therapeutics, Inc. (Appearances: H. Ray, III, J. Morris, J. Dickenson, R. Trechtor, and M. Stromberg for Senynl; W. Martin, R. Parisi, and M. Venus for Liquidating Trustee; J. Brookner and E. Shanks for EIT; C. Carson for Progeria Foundation. Nonevidentiary status conference. After hearing statements of counsel, court determined this contested matter will be tried jointly with Motion to Enforce Zokinvy Sale Order, DE # 779, all parties agreeing that no adversary proceeding is needed/requested. This matter will also be tried with EIT Motion at DE # 787. Joint Scheduling Order to be submitted.) Edmond, Michael) |
| 04/15/2025 | 820 | Order granting motion to appear pro hac vice adding Reed Trechter for Sentynl Therapeutics, Inc. (related document # [811]) Entered on 4/15/2025. (Rielly, Bill) |
| 04/15/2025 | 819 | Motion to file document under seal./ Progeria Research Foundation's Emergency Motion for Entry of an Order Authorizing Progeria Research Foundation to File Its Response Under Seal Filed by Interested Party Progeria Research Foundation (Attachments: # (1) Exhibit A - Proposed Order) (Crozier, Jennifer) |